|
The Prediction of Alzheimer’s Disease through Multi-Trait Genetic Modeling (via DSS) |
|
|
|
|
Progressive Supranuclear Palsy (PSP) Summary Statistics- Hoglinger et al. (2011) |
|
|
|
|
IGAP APOE-Stratified Analysis Summary Statistics- Jun et al. (2015) |
|
|
|
|
Resolving mutations in challenging genomic regions to test association with disease phenotypes (via DSS) |
|
|
|
|
Sex differences in the genetic predictors of Alzheimer’s pathology – Dumitrescu et al., 2019 (via DSS) |
|
|
|
|
Results of gene-based weighted burden analyses using SCOREASSOC and GENEVARASSOC applied to the ADSP discovery sample |
|
|
|
|
Large scale genetics study on CSF and brain metabolite levels (via DSS) |
|
|
|
|
UAB/HudsonAlpha Families with Neurodegenerative Diseases |
|
|
|
|
Longitudinal Change in Memory Performance as a Strong Endophenotype for Alzheimer’s – Archer, et al, 2023 (via DSS) |
|
|
|
|
Summary Statistics of IGAP Age at onset survival GWAS dataset - Huang KL et al. (2017) |
|
|
|
|
ADGC Age at Onset Summary Statistics- Naj et al. (2014) |
|
|
|
|
Circular RNAs in Alzheimer Disease Brains - RNA-seq Data |
|
|
|
|
Sex-specific genetic architecture of late-life memory performance (via DSS) |
|
|
|
|
eGWAS Mayo |
|
|
|
|
Safety and pharmacokinetics of a highly bioavailable resveratrol preparation(JOTROL TM) (via DSS) |
|
|
|
|
IGAP Summary Statistics- Lambert et al. (2013) |
|
|
|
|
Genome-wide summary statistics for cognitively defined late-onset Alzheimer’s disease subgroups |
|
|
|
|
CSF Summary Statistics- Cruchaga et al. (2013) |
|
|
|
|
Immune-related genetic enrichment in FTD summary statistics- Broce et al. 2018 |
|
|
|
|
Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease – Eissman et al., 2022 (via DSS) |
|
|
|
